EUVIMEDEUVIMED entdecken
Crossref

LINAC-Based Stereotactic Body Radiation Therapy for Benign Tumors of the Skull Base

Anna Lee, He C. Wang, Xin A. Wang, Amy C. Moreno, Jay P. Reddy, Michael T. Spiotto, David I. Rosenthal, Shaan M. Raza, Franco DeMonte, Paul W. Gidley, Marc-Elie Nader, Shirley Y. Su und 3 weitere

Journal of Neurological Surgery Part B: Skull Base · 01.02.2023 · 84 (S 01 S 01) · S1-S344

DOI: 10.1055/s-0043-1762452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2023. Verfasst von Anna Lee und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Benign tumors of the skull base are relatively rare entities that are difficult to treat given their proximity to critical structures. While slow growing, surgical resection can be associated with high morbidity rates. We present our institutional experience in treating benign skull base tumors with linear accelerator (LINAC)-based stereotactic body radiation therapy (SBRT).

Methods

This is a retrospective analysis of outcomes of patients presenting with a benign tumor of the skull base treated with LINAC-based SBRT. Patients who were enrolled in our prospective skull base registry and treated between 2017 and 2022 were included. All patients were evaluated for surgery and the risk of potential cranial nerve injury was the primary reason for consideration of radiation therapy. Outcomes of interest included local control (LC), overall survival (OS) and toxicity. Local control was defined as radiographic evidence of lack of progression. Follow-up interval was defined as from the end of SBRT to last follow-up.

Results

Twenty-six patients formed the cohort. The median age was 51 years. Nineteen cases were paragangliomas, 6 were schwannomas and 1 was a myxoid tumor. The distribution of treated sites was the following: jugular foramen/jugulotympanicum, 22; carotid space, 2; hypoglossal canal, 1; petrous apex, 1. Indications for treatment were growth and/or symptomatic progression. Hearing loss and tinnitus were the most common reported symptoms. All but one patient had gross disease at the time of SBRT as one patient was treated after resection. Four patients with gross disease had prior treatment; 3 patients had prior surgery and 1 patient had prior fractionated radiation. The median target volume was 13.5 cm3 (range: 1.32–48.5 cm 3 ) and the median prescribed dose was 27 Gy in 3 fractions (range: 21–36 Gy in 3–5 fractions). The median prescription coverage of the tumor was 96% (range: 86–100%). At a median follow-up of 22 months, all patients were alive with LC at last follow-up. The treated tumors were radiographically stable in all 25 patients treated for gross disease, and the patient treated adjuvantly remained disease free. Fifteen patients (58%) reported some improvement of initial symptoms and the remaining 11 patients (42%) had no worsening of pre-treatment symptoms. Following SBRT, there was 1 grade 1 tinnitus, 1 grade 2 facial nerve palsy, and 1 grade 2 nausea, but no grade 3 or higher toxicities.

Conclusions

In this largest series to date, SBRT for benign skull base tumors resulted in excellent local control, minimal toxicity and improvement in presenting symptoms. SBRT is a favorable treatment option for those who would otherwise have potentially significant cranial nerve injury following surgical resection. Publication History Article published online: 01 February 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Lee, A., Wang, H. C., Wang, X. A., Moreno, A. C., Reddy, J. P., Spiotto, M. T., Rosenthal, D. I., Raza, S. M., DeMonte, F., Gidley, P. W., Nader, M., Su, S. Y., Hanna, E. Y., Garden, A. S., & Phan, J. (2023). LINAC-Based Stereotactic Body Radiation Therapy for Benign Tumors of the Skull Base. Journal of Neurological Surgery Part B: Skull Base, 84(S 01 S 01), S1-S344. https://doi.org/10.1055/s-0043-1762452

Vancouver

Lee A, Wang HC, Wang XA, Moreno AC, Reddy JP, Spiotto MT, et al. LINAC-Based Stereotactic Body Radiation Therapy for Benign Tumors of the Skull Base. Journal of Neurological Surgery Part B: Skull Base. 2023;84(S 01 S 01):S1-S344. doi:10.1055/s-0043-1762452

BibTeX
@article{Lee2023,
  author = {Lee, Anna and Wang, He C. and Wang, Xin A. and Moreno, Amy C. and Reddy, Jay P. and Spiotto, Michael T. and Rosenthal, David I. and Raza, Shaan M. and DeMonte, Franco and Gidley, Paul W. and Nader, Marc-Elie and Su, Shirley Y. and Hanna, Ehab Y. and Garden, Adam S. and Phan, Jack},
  title = {LINAC-Based Stereotactic Body Radiation Therapy for Benign Tumors of the Skull Base},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2023},
  volume = {84},
  number = {S 01 S 01},
  pages = {S1--S344},
  doi = {10.1055/s-0043-1762452}
}
Kostenlos starten →